Lexeo Therapeutics
LXEO
LXEO
144 hedge funds and large institutions have $759M invested in Lexeo Therapeutics in 2025 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 60 increasing their positions, 26 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
13.35% more ownership
Funds ownership: 91.4% → 104.76% (+13%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less call options, than puts
Call options by funds: $136K | Put options by funds: $143K
Holders
144
Holding in Top 10
1
Calls
$136K
Puts
$143K
Top Buyers
| 1 | +$45.6M | |
| 2 | +$43.5M | |
| 3 | +$30.1M | |
| 4 |
BlackRock
New York
|
+$25M |
| 5 |
State Street
Boston,
Massachusetts
|
+$24.1M |
Top Sellers
| 1 | -$20.8M | |
| 2 | -$12.8M | |
| 3 | -$6.5M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$6.12M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$5.44M |
